LCHN_E330009J07Rik Activators
LCHN Activators comprise an array of chemical compounds that indirectly amplify the functional activity of LCHN through distinct signaling pathways. Forskolin, for instance, indirectly enhances LCHN's function by activating adenylyl cyclase, which increases cAMP levels and, in turn, activates PKA; this kinase phosphorylates various substrates that can include those within LCHN's signaling network, thereby boosting its activity. Similarly, IBMX, by preventing cAMP degradation, and Dibutyryl cAMP, as a synthetic analog, both raise cAMP levels, leading to PKA-mediated activation of proteins that are part of LCHN's functional repertoire.
Glucokinase Activators consist of a variety of chemical compounds that enhance the catalytic function of Glucokinase through multiple mechanisms. The enzymatic activity of Glucokinase is directly increased by its primary substrate, glucose, as higher glucose concentrations facilitate its phosphorylation activity. Fructose and Sorbitol, after metabolic conversion, contribute to intracellular fructose-1-phosphate levels, which can mitigate the inhibition exerted by Glucokinase regulatory protein, thereby freeing Glucokinase to phosphorylate glucose. Similarly, Mannose and Glyceraldehyde, through their phosphorylated metabolites, may exert positive effects on Glucokinase, although their actions are less well-characterized.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterases which increases intracellular cAMP levels by preventing its breakdown, thereby potentiating PKA activation and enhancing the activity of downstream proteins including LCHN. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent protein kinase C (PKC) activator. PKC activation can lead to the phosphorylation of target proteins and the modulation of signaling pathways that LCHN is involved in, resulting in enhanced activity of LCHN. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is an ionophore that increases intracellular calcium levels, which can activate calcium/calmodulin-dependent protein kinases and other calcium-sensitive signaling mechanisms that indirectly lead to the activation of LCHN. | ||||||
Spermine | 71-44-3 | sc-212953A sc-212953 sc-212953B sc-212953C | 1 g 5 g 25 g 100 g | $61.00 $196.00 $277.00 $901.00 | 1 | |
Spermine is a polyamine that can modulate ion channels and may influence intracellular signaling cascades that include kinases and phosphatases, thereby potentially enhancing the activity of LCHN through these pathways. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a protein synthesis inhibitor that can also activate stress-activated protein kinases (SAPKs) like JNK. Activation of JNK and other SAPKs can indirectly enhance LCHN activity by modulating the stress response pathways in which LCHN is involved. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is a potent inhibitor of protein phosphatases PP1 and PP2A, leading to increased phosphorylation levels of cellular proteins, which could enhance LCHN's activity if it is regulated by phosphorylation downstream of these phosphatases. | ||||||